Abstract| Volume 116, P73, December 2022

O18Trends in copper versus hormonal intrauterine device breakage reporting within the us food and drug administration adverse event reporting system

      This paper is only available as a PDF. To read, Please Download here.


      Intrauterine devices (IUDs) are a commonly used form of female contraception. While insertion/removal is typically uncomplicated, the media has drawn attention to reports of IUDs breaking upon removal, with particular concern about increased likelihood of breakage with copper IUDs. We used national pharmacovigilance data to examine trends in the reporting of broken IUDs.


      We examined the Food and Drug Administration Adverse Event Reporting System (FAERS)’s reports for IUDs, with interest in “breakage.” We explored associations of breakage with IUD type (copper vs. hormonal), year reported, reporter (consumer vs. clinician), and patient characteristics (age and weight).


      We identified 170,360 adverse reports for all types of IUDs (43,230 copper and 127,130 hormonal). 9.59% (n=4,147) of copper IUD adverse events were breakages. In contrast, 1.69% (n=2,147) of adverse events for hormonal IUDs were breakages. In a disproportionality analysis comparing breakage reports for copper IUDs to hormonal IUDs, adverse events for copper vs. those for hormonal IUDs were 6.18 times more likely (95% CI, 5.86–6.52) to be a breakage report. IUD breakages were also associated with older, heavier-weight individuals. Finally, breakage reports were disproportionately filed by clinicians compared with non-clinicians (OR, 1.36; 95% CI, 1.29–1.43).


      National pharmacovigilance data show disproportionate breakage in copper vs. hormonal IUDs. Long term surveillance using publicly collected data may reveal events that occur after prolonged use. This data can supplement patients’ anecdotal experiences and help provide better counseling.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect